Due to the prevalence of ultrasonography and mammography, the diagnosis of breast carcinoma can be made at the earliest, thereby decreasing its mortality rate. However, there are cases where patients present in the later stage with lung, bone, brain, or liver metastases, which require further evaluation. Metastatic disease to the liver from breast carcinoma is a known site, which can be hypovascular or hypervascular masses. Cross-sectional imaging, including CT, MRI, and PET-CT, is helpful in diagnosing and staging the disease process.